Savvy Advisors Inc. Grows Stock Holdings in CME Group Inc. $CME

Savvy Advisors Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 129.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,001 shares of the financial services provider’s stock after buying an additional 1,695 shares during the quarter. Savvy Advisors Inc.’s holdings in CME Group were worth $819,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CME. Stratos Wealth Partners LTD. lifted its stake in CME Group by 475.0% in the 4th quarter. Stratos Wealth Partners LTD. now owns 13,214 shares of the financial services provider’s stock worth $3,609,000 after purchasing an additional 10,916 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its stake in CME Group by 294.7% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 150 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 112 shares in the last quarter. 1900 Wealth Management LLC lifted its stake in CME Group by 2.1% in the 4th quarter. 1900 Wealth Management LLC now owns 1,999 shares of the financial services provider’s stock worth $546,000 after purchasing an additional 41 shares in the last quarter. Essex LLC lifted its stake in CME Group by 2.0% in the 4th quarter. Essex LLC now owns 2,280 shares of the financial services provider’s stock worth $623,000 after purchasing an additional 45 shares in the last quarter. Finally, Tower Wealth Partners Inc. lifted its stake in CME Group by 4.8% in the 4th quarter. Tower Wealth Partners Inc. now owns 1,915 shares of the financial services provider’s stock worth $523,000 after purchasing an additional 87 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on CME shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research note on Thursday, February 5th. Argus reiterated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. UBS Group reiterated a “neutral” rating and issued a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. Finally, Weiss Ratings upgraded shares of CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a report on Monday, March 2nd. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Moderate Buy” and a consensus price target of $304.65.

CME Group Stock Performance

CME Group stock opened at $310.58 on Wednesday. The company’s 50-day moving average price is $305.72 and its 200-day moving average price is $283.93. CME Group Inc. has a twelve month low of $248.53 and a twelve month high of $329.16. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The company has a market cap of $111.38 billion, a PE ratio of 27.83, a price-to-earnings-growth ratio of 3.25 and a beta of 0.26.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.52 EPS. On average, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date was Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is currently 46.59%.

Insider Activity

In related news, Director Bryan T. Durkin sold 4,200 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the transaction, the director owned 24,999 shares in the company, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is currently owned by company insiders.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME will list AVAX and SUI futures (micro and larger contract sizes) effective May 4 pending review — expands its regulated crypto product set and makes high-growth tokens accessible to institutional and retail futures traders, which should support trading volumes and fee revenue. PR Newswire: CME Group to Continue Expansion of Regulated Crypto Suite
• Positive Sentiment: Management and coverage note strong crypto derivatives demand (CME reported ~ $8 billion average daily notional in March), signaling an expanding revenue pool for new listings like AVAX and SUI. Blockonomi: CME Group to Launch Avalanche and Sui Futures on May 4
• Positive Sentiment: Sell-side support: Raymond James raised its price target to $320 (maintaining an Outperform), providing incremental analyst validation that may encourage buy-side interest. MarketScreener: Raymond James Adjusts Price Target on CME Group
• Neutral Sentiment: The launches are subject to regulatory review — approval timing and any conditions remain a gating risk that could delay or alter revenue upside from these new contracts. Cointelegraph: CME Group expands crypto futures with Avalanche and Sui contracts

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.